<?xml version="1.0" encoding="UTF-8"?>
<legiscan><status></status><bill><bill_id>477481</bill_id><change_hash>525845b0ef673ca9928b117126e0b46f</change_hash><session><session_id>1008</session_id><session_name>2013 Regular Session</session_name></session><url>http://legiscan.com/MS/bill/HB1387/2013</url><state_link>http://billstatus.ls.state.ms.us/2013/pdf/history/HB/HB1387.xml</state_link><completed>1</completed><status>6</status><status_date>2013-02-05</status_date><progress><step><date>2013-01-21</date><event>1</event></step><step><date>2013-01-21</date><event>9</event></step><step><date>2013-02-05</date><event>6</event></step></progress><state>MS</state><state_id>24</state_id><bill_number>HB1387</bill_number><bill_type>B</bill_type><body>H</body><body_id>57</body_id><current_body>H</current_body><current_body_id>57</current_body_id><title>Prescription biosimilar product; authorize substitution by pharmacists.</title><description>An Act To Create New Section 73-21-118, Mississippi Code Of 1972, To Authorize The Substitution Of Interchangeable Biological Products For A Prescribed Product By A Pharmacist Under Certain Circumstances; And For Related Purposes.</description><committee/><history><step><date>2013-01-21</date><action>Referred To Public Health and Human Services</action><chamber>H</chamber><chamber_id>57</chamber_id><importance>1</importance></step><step><date>2013-02-05</date><action>Died In Committee</action><chamber>H</chamber><chamber_id>57</chamber_id><importance>1</importance></step></history><sponsors><sponsor><people_id>6523</people_id><name>Bobby Moak</name><role_id>1</role_id><ftm_id>422</ftm_id><sponsor_type_id>1</sponsor_type_id><sponsor_order>1</sponsor_order></sponsor></sponsors><texts><text><doc_id>711288</doc_id><date>2013-01-29</date><type>Introduced</type><mime>text/html</mime><url>http://legiscan.com/MS/text/HB1387/id/711288</url><state_link>http://billstatus.ls.state.ms.us/documents/2013/html/HB/1300-1399/HB1387IN.htm</state_link></text></texts></bill></legiscan>
